Abbott/TheraSense: A Subtext Beyond the Diabetes Market?

Abbott's TheraSense acquisition clearly helps resurrect its flagging MediSense diabetes device business. It may also signal a new aggressiveness for Abbott as it emerges from the long shadow of an FDA consent decree.